One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Contract Research Organization (CRO) Services Market

Contract Research Organization (CRO) Services Market (Service Type: Early Phase Development [Discovery Services, Chemistry, and Preclinical Services], Clinical Research Services [Phase I, Phase II, Phase III, and Phase IV], Laboratory Services [Bioanalytical Services, Analytical Services, and Others], and Consulting Services; Therapeutic Indication: Oncology, Infectious Diseases, Immunological Disorders, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, and Others; and End U


Product Code : TMRHC00110434
Survey : Transparency Market Research
Publish On : 20, May, 2022
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5795 / Question Form
5 User USD8795 / Question Form
Enterprise User USD11795 / Question Form

[Report Description]

Contract Research Organization (CRO) Services Market: Overview




  • The global contract research organization (CRO) Services market was valued at ~US$ 49 Bn in 2018 and is projected to expand at a high CAGR from 2019 to 2027. The global market is driven by increased spending on research and development by manufacturers, patent expiries of various biologics leading to increase in the number of clinical trials, rising penetration of CROs, and growing focus of market players on conducting clinical trials in emerging markets.

  • Contract research organizations (CROs) are engaged in offering a range of research services on a contract basis to pharmaceutical, medical device, and biotechnology companies

  • Large biopharmaceutical companies have been outsourcing most of their research and development activities in order to shift from fixed costs to variable costs, increase their access to new technological capabilities, and expand their global reach. This is promoting growth of the global contract research organization (CRO) services market.

  • Rising prevalence of cancer globally is a key factor driving the number of clinical trials being conducted. Furthermore, the global number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. 



Contract Research Organization (CRO) Services: Market Segmentation




  • The global contract research organization (CRO) services market has been segmented based on service type, therapeutic indication, end user, and region

  • In terms of service type, the global contract research organization (CRO) services market has been categorized into early phase development, clinical research services, laboratory services, and consulting services. The early phase development segment has been sub-segmented into discovery services, chemistry, and preclinical services. The preclinical services sub-segment has been further divided into toxicology, pharmacokinetics, and others. The clinical research services segment has been sub-classified into phase I, phase II, phase III, and phase IV. The laboratory services segment has been sub-categorized into bioanalytical services, analytical services, and others.

  • Based on therapeutic indication, the global contract research organization (CRO) services market has been segregated into oncology, infectious diseases, immunological diseases, respiratory diseases, cardiovascular diseases, neurological disorders, and others

  • Based on end user, the global contract research organization (CRO) services market has been divided into medical device companies, biopharmaceutical companies, and others 



Contract Research Organization (CRO) Services Market: Regional Segmentation




  • In terms of region, the global contract research organization (CRO) services market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

  • North America dominated the global contract research organization (CRO) services market in 2018 and the trend is expected to continue throughout the forecast period

  • The contract research organization (CRO) services market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. Japan is one of the largest industries for clinical trials in Asia Pacific and it witnesses significant product registrations. Large-sized CROs operating worldwide are focused on expanding their presence in Japan through investments in facilities and resources in functional services such as central laboratories, imaging, and clinical supplies. 



Contract Research Organization (CRO) Services Market: Major Players




  • Key players operating in the global contract research organization (CRO) services market are

    • Laboratory Corporation of America Holdings

    • IQVIA Inc.

    • Syneos Health, Inc.

    • Parexel International Corporation

    • PRA Health Sciences, Inc.

    • PPD, Inc.

    • Charles River Laboratories, Inc.

    • Icon plc

    • WuXi AppTec Group

    • Medpace



  • These players are focused on adopting inorganic growth strategies to strengthen their product portfolio. These companies have adopted strategies such as partnerships and acquisitions to strengthen their market position, expand their portfolio of services, and expand their geographical presence. 



Contract Research Organization (CRO) Services Market - Scope of the Report



The report on the global contract research organization (CRO) services market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the global market during the forecast period i.e. from 2019 to 2027. The report provides the overall revenue of the global contract research organization (CRO) services market for the 2017–2027 period, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compounded annual growth rate (CAGR) for the global contract research organization (CRO) services market for the forecast period.



The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with market leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global contract research organization (CRO) services market.



Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global contract research organization (CRO) services market.



The report includes an elaborate executive summary, along with a snapshot of the growth pattern of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on the changing competition dynamics in the global contract research organization (CRO) services market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global contract research organization (CRO) services market. The next section of the report highlights the USPs, which include regulatory scenarios for contract research organization (CRO) services globally, business models, pricing analysis, and market developments in the global contract research organization (CRO) services market.



The report delves into the competition landscape of the global contract research organization (CRO) services market. Key players operating in the global contract research organization (CRO) services market have been identified and each one of these has been profiled for its distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global contract research organization (CRO) services market report.



Key Questions Answered in Contract Research Organization (CRO) Services Market Report




  • How much sales revenue would be generated by CRO services across all regions during the forecast period?

  • What are key trends in the global contract research organization (CRO) services market?

  • What are major drivers, restraints, and opportunities in the global contract research organization (CRO) services market?

  • Which regional market is set to expand at the most rapid CAGR during the forecast period?

  • Which segment would generate the maximum revenue by 2027 and which service type segment would expand at the most rapid CAGR during the forecast period?



Contract Research Organization (CRO) Services Market - Research Objectives and Research Approach



The comprehensive report on the global contract research organization (CRO) services market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and health care compliances laid down by accredited agencies in the purview of research in the global contract research organization (CRO) services market. It is followed by market introduction, market dynamics, and an overview of the global contract research organization (CRO) services market, which includes analysis of market drivers, restraints, and trends affecting the market. Furthermore, Y-o-Y growth analysis with elaborate insights has been provided to understand the Y-o-Y growth trends of the global market. The next section of the global contract research organization (CRO) services market report highlights the USPs, which include regulatory scenarios for contract research organization (CRO) services globally, market value chain analysis, and developments in the global market.



For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections. The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.



Revenue generated by key players in the contract research organization (CRO) services market has been mapped to ascertain the size of the global contract research organization (CRO) services market, in terms of value. The forecast presented here assesses the total revenue generated in the global contract research organization (CRO) services market. In order to provide an accurate forecast, we initiated by sizing up the current contract research organization (CRO) services market with the help of the parent market.



The report analyzes the global contract research organization (CRO) services market in terms of service type, therapeutic indication, and end user. Key segments under each criteria have been studied at length and the market share for each of these by the end of 2027 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global contract research organization (CRO) services market.


1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary: Global Contract Research Organization (CRO) Services Market

5. Market Overview

5.1. Definition

5.2. Market Indicators

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunities

6. Market Outlook

6.1. Global Contract Research Organization (CRO) Services Market Revenue (US$ Mn) Forecast 2017–2027

6.2. Global Contract Research Organization (CRO) Services Market Outlook

6.3. Regulatory Scenario, by Region/Global

6.4. Clinical Trials Analysis

6.5. Key Mergers and Acquisitions

6.6. Heat Map Analysis

6.7. CROs - Business Model

6.8. CROs - Pricing Strategies

7. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Service Type

7.1. Introduction

7.2. Global CRO Services Market Value Share Analysis, by Service Type

7.3. Global CRO Services Market Value Forecast, by Service Type, 2017–2027

7.3.1. Early Phase Development

7.3.1.1. Discovery Services

7.3.1.2. Chemistry

7.3.1.3. Preclinical Services

7.3.1.3.1. Toxicology

7.3.1.3.2. Pharmacokinetics

7.3.1.3.3. Others

7.3.2. Clinical Research Services

7.3.2.1. Phase I

7.3.2.2. Phase II

7.3.2.3. Phase III

7.3.2.4. Phase IV

7.3.3. Laboratory Services

7.3.3.1. Bioanalytical Services

7.3.3.2. Analytical Services

7.3.3.3. Others

7.3.4. Consulting Services

7.4. Global CRO Services Market Attractiveness, by Service Type

8. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Therapeutic Indication

8.1. Introduction

8.2. Global CRO Services Market Value Share Analysis, by Therapeutic Indication

8.3. Global CRO Services Market Value Forecast, by Therapeutic Indication, 2017–2027

8.3.1. Oncology

8.3.2. Infectious Diseases

8.3.3. Immunological Disorders

8.3.4. Respiratory Diseases

8.3.5. Cardiovascular Diseases

8.3.6. Neurological Disorders

8.3.7. Others

8.4. Global CRO Services Market Attractiveness, by Therapeutic Indication

9. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by End-user

9.1. Introduction

9.2. Global CRO Services Market Value Share Analysis, by End-user

9.3. Global CRO Services Market Value Forecast, by End-user, 2017–2027

9.3.1. Medical Device Companies

9.3.2. Biopharmaceutical Companies

9.3.3. Others

9.4. Global CRO Services Market Attractiveness, by End-user

10. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Region

10.1. Regional Outlook

10.2. Global Scenario

10.3. Introduction

10.4. Global Contract Research Organization (CRO) Services Market Value Forecast, by Region

10.4.1. North America

10.4.2. Europe

10.4.3. Asia Pacific

10.4.4. Latin America

10.4.5. Middle East & Africa

10.5. Global CRO Services Market Attractiveness, by Region

11. North America Contract Research Organization (CRO) Services Market Analysis and Forecast

11.1. Key Findings

11.2. North America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

11.2.1. Early Phase Development

11.2.1.1. Discovery Services

11.2.1.2. Chemistry

11.2.1.3. Preclinical Services

11.2.1.3.1. Toxicology

11.2.1.3.2. Pharmacokinetics

11.2.1.3.3. Others

11.2.2. Clinical Research Services

11.2.2.1. Phase I

11.2.2.2. Phase II

11.2.2.3. Phase III

11.2.2.4. Phase IV

11.2.3. Laboratory Services

11.2.3.1. Bioanalytical Services

11.2.3.2. Analytical Services

11.2.3.3. Others

11.2.4. Consulting Services

11.3. North America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

11.3.1. Oncology

11.3.2. Infectious Diseases

11.3.3. Immunological Disorders

11.3.4. Respiratory Diseases

11.3.5. Cardiovascular Diseases

11.3.6. Neurological Disorders

11.3.7. Others

11.4. North America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

11.4.1. Medical Device Companies

11.4.2. Biopharmaceutical Companies

11.4.3. Others

11.5. North America Contract Research Organization (CRO) Services Market Value Forecast, by Country, 2017–2027

11.5.1. U.S.

11.5.2. Canada

11.6. North America Contract Research Organization (CRO) Services Market Attractiveness Analysis

11.6.1. By Service Type

11.6.2. By Therapeutic Indication

11.6.3. By End-user

11.6.4. By Country

12. Europe Contract Research Organization (CRO) Services Market Analysis and Forecast

12.1. Key Findings

12.2. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

12.2.1. Early Phase Development

12.2.1.1. Discovery Services

12.2.1.2. Chemistry

12.2.1.3. Preclinical Services

12.2.1.3.1. Toxicology

12.2.1.3.2. Pharmacokinetics

12.2.1.3.3. Others

12.2.2. Clinical Research Services

12.2.2.1. Phase I

12.2.2.2. Phase II

12.2.2.3. Phase III

12.2.2.4. Phase IV

12.2.3. Laboratory Services

12.2.3.1. Bioanalytical Services

12.2.3.2. Analytical Services

12.2.3.3. Others

12.2.4. Consulting Services

12.3. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

12.3.1. Oncology

12.3.2. Infectious Diseases

12.3.3. Immunological Disorders

12.3.4. Respiratory Diseases

12.3.5. Cardiovascular Diseases

12.3.6. Neurological Disorders

12.3.7. Others

12.4. Europe Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

12.4.1. Medical Device Companies

12.4.2. Biopharmaceutical Companies

12.4.3. Others

12.5. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. U.K.

12.5.2. Germany

12.5.3. France

12.5.4. Italy

12.5.5. Spain

12.5.6. Rest of Europe

12.6. Europe Contract Research Organization (CRO) Services Market Attractiveness Analysis

12.6.1. By Service Type

12.6.2. By Therapeutic Indication

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Asia Pacific Contract Research Organization (CRO) Services Market Analysis and Forecast

13.1. Key Findings

13.2. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

13.2.1. Early Phase Development

13.2.1.1. Discovery Services

13.2.1.2. Chemistry

13.2.1.3. Preclinical Services

13.2.1.3.1. Toxicology

13.2.1.3.2. Pharmacokinetics

13.2.1.3.3. Others

13.2.2. Clinical Research Services

13.2.2.1. Phase I

13.2.2.2. Phase II

13.2.2.3. Phase III

13.2.2.4. Phase IV

13.2.3. Laboratory Services

13.2.3.1. Bioanalytical Services

13.2.3.2. Analytical Services

13.2.3.3. Others

13.2.4. Consulting Services

13.3. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

13.3.1. Oncology

13.3.2. Infectious Diseases

13.3.3. Immunological Disorders

13.3.4. Respiratory Diseases

13.3.5. Cardiovascular Diseases

13.3.6. Neurological Disorders

13.3.7. Others

13.4. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

13.4.1. Medical Device Companies

13.4.2. Biopharmaceutical Companies

13.4.3. Others

13.5. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. China

13.5.2. India

13.5.3. Japan

13.5.4. Australia & New Zealand

13.5.5. Rest of Asia Pacific

13.6. Asia Pacific Contract Research Organization (CRO) Services Market Attractiveness Analysis

13.6.1. By Service Type

13.6.2. By Therapeutic Indication

13.6.3. By End-user

13.6.4. By Country/Sub-region

14. Latin America Contract Research Organization (CRO) Services Market Analysis and Forecast

14.1. Key Findings

14.2. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

14.2.1. Early Phase Development

14.2.1.1. Discovery Services

14.2.1.2. Chemistry

14.2.1.3. Preclinical Services

14.2.1.3.1. Toxicology

14.2.1.3.2. Pharmacokinetics

14.2.1.3.3. Others

14.2.2. Clinical Research Services

14.2.2.1. Phase I

14.2.2.2. Phase II

14.2.2.3. Phase III

14.2.2.4. Phase IV

14.2.3. Laboratory Services

14.2.3.1. Bioanalytical Services

14.2.3.2. Analytical Services

14.2.3.3. Others

14.2.4. Consulting Services

14.3. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

14.3.1. Oncology

14.3.2. Infectious Diseases

14.3.3. Immunological Disorders

14.3.4. Respiratory Diseases

14.3.5. Cardiovascular Diseases

14.3.6. Neurological Disorders

14.3.7. Others

14.4. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

14.4.1. Medical Device Companies

14.4.2. Biopharmaceutical Companies

14.4.3. Others

14.5. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

14.5.1. Brazil

14.5.2. Mexico

14.5.3. Rest of Latin America

14.6. Latin America Contract Research Organization (CRO) Services Market Attractiveness Analysis

14.6.1. By Service

14.6.2. By Therapeutic Indication

14.6.3. By End-user

14.6.4. By Country/Sub-region

15. Middle East & Africa Contract Research Organization (CRO) Services Market Analysis and Forecast

15.1. Key Findings

15.2. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

15.2.1. Early Phase Development

15.2.1.1. Discovery Services

15.2.1.2. Chemistry

15.2.1.3. Preclinical Services

15.2.1.3.1. Toxicology

15.2.1.3.2. Pharmacokinetics

15.2.1.3.3. Others

15.2.2. Clinical Research Services

15.2.2.1. Phase I

15.2.2.2. Phase II

15.2.2.3. Phase III

15.2.2.4. Phase IV

15.2.3. Laboratory Services

15.2.3.1. Bioanalytical Services

15.2.3.2. Analytical Services

15.2.3.3. Others

15.2.4. Consulting Services

15.3. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

15.3.1. Oncology

15.3.2. Infectious Diseases

15.3.3. Immunological Disorders

15.3.4. Respiratory Diseases

15.3.5. Cardiovascular Diseases

15.3.6. Neurological Disorders

15.3.7. Others

15.4. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

15.4.1. Medical Device Companies

15.4.2. Biopharmaceutical Companies

15.4.3. Others

15.5. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

15.5.1. GCC

15.5.2. South Africa

15.5.3. Rest of Middle East & Africa

15.6. Middle East & Africa Contract Research Organization (CRO) Services Market Attractiveness Analysis

15.6.1. By Service

15.6.2. By Therapeutic Indication

15.6.3. By End-user

15.6.4. By Country/Sub-region

16. Competition Landscape

16.1. Competition Matrix

16.2. Global CRO Services Market Share Analysis, by Company, 2018

16.3. Company Profiles

16.3.1. Laboratory Corporation of America Holdings

16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.1.2. Financial Overview

16.3.1.3. Product Portfolio

16.3.1.4. Strategic Overview

16.3.1.5. SWOT Analysis

16.3.2. IQVIA Inc.

16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.2.2. Financial Overview

16.3.2.3. Product Portfolio

16.3.2.4. Strategic Overview

16.3.2.5. SWOT Analysis

16.3.3. Syneos Health, Inc.

16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.3.2. Financial Overview

16.3.3.3. Product Portfolio

16.3.3.4. Strategic Overview

16.3.3.5. SWOT Analysis

16.3.4. Parexel International Corporation

16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.4.2. Financial Overview

16.3.4.3. Product Portfolio

16.3.4.4. Strategic Overview

16.3.4.5. SWOT Analysis

16.3.5. PRA Health Sciences, Inc.

16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.5.2. Financial Overview

16.3.5.3. Product Portfolio

16.3.5.4. Strategic Overview

16.3.5.5. SWOT Analysis

16.3.6. PPD, Inc.

16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.6.2. Financial Overview

16.3.6.3. Product Portfolio

16.3.6.4. Strategic Overview

16.3.6.5. SWOT Analysis

16.3.7. Charles River Laboratories, Inc.

16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.7.2. Financial Overview

16.3.7.3. Product Portfolio

16.3.7.4. Strategic Overview

16.3.7.5. SWOT Analysis

16.3.8. Icon plc

16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.8.2. Financial Overview

16.3.8.3. Product Portfolio

16.3.8.4. Strategic Overview

16.3.8.5. SWOT Analysis

16.3.9. WuXi AppTec Group

16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.9.2. Financial Overview

16.3.9.3. Product Portfolio

16.3.9.4. Strategic Overview

16.3.9.5. SWOT Analysis

16.3.10. Medpace

16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.3.10.2. Financial Overview

16.3.10.3. Product Portfolio

16.3.10.4. Strategic Overview

16.3.10.5. SWOT Analysis

List of Tables



Table 01: CROs - Heat Map Analysis

Table 02: CROs – Business Models

Table 03: Global CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 04: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 05: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 06: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 07: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 08: Global CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 09: Global CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 10: Global CRO Services Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 11: North America CRO Services Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 12: North America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 13: North America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 14: North America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 15: North America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 16: North America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 17: North America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 18: North America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 19: Europe CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20: Europe CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 21: Europe CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 22: Europe CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 23: Europe CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 24: Europe CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 25: Europe CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 26: Europe CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 27: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 28: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 29: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 30: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 31: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 32: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 33: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 34: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 35: Latin America CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 36: Latin America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 37: Latin America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 38: Latin America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 39: Latin America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 40: Latin America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 41: Latin America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 42: Latin America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 43: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 44: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

Table 45: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Table 46: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Table 47: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Table 48: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Table 49: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

Table 50: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures



Figure 01: Global Contract Research Organization (CRO) Services Market Snapshot

Figure 02: Global Contract Research Organization (CRO) Services Market Value (US$ Mn), by Region, 2019 and 2027

Figure 03: Penetration of Clinical CRO Outsourcing Services

Figure 04: Increase in Clinical Trials

Figure 05: Global CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 06: Global CRO Services Market Value Share (%), by Service Type (2019)

Figure 07: Global CRO Services Market Value Share (%), by Therapeutic Indication (2019)

Figure 08: Global CRO Services Market Value Share (%), by End-user (2019)

Figure 09: Global CRO Services Market Value Share (%), by Region (2019)

Figure 10: Regulatory Scenario – North America

Figure 11: Regulatory Scenario – Europe

Figure 12: Regulatory Scenario – Asia Pacific

Figure 13: Number of Registered Studies, by Location

Figure 14: Number of Registered Studies, by Intervention

Figure 15: Global CRO Services Market – Key Mergers and Acquisitions

Figure 16: CROs- Pricing Strategies

Figure 17: Key Strategies – Laboratory Corporation of America Holdings (LabCorp)

Figure 18: Key Strategies – IQVIA

Figure 19: Global CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 20: Global CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 21: Global CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 22: Global CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 23: Global CRO Services Market Value Share Analysis, by Preclinical Services, 2018 and 2027

Figure 24: Global CRO Services Market Attractiveness, by Preclinical Services, 2019?2027

Figure 25: Global CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 26: Global CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 27: Global CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 28: Global CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 29: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

Figure 30: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

Figure 31: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

Figure 32: Global CRO Services Market Value (US$ Mn) Forecast, by Consulting Services, 2017–2027

Figure 33: Global CRO Services Market Value (US$ Mn) Forecast, by Discovery Services, 2017–2027

Figure 34: Global CRO Services Market Value (US$ Mn) Forecast, by Chemistry, 2017–2027

Figure 35: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

Figure 36: Global CRO Services Market Value (US$ Mn) Forecast, by Phase I, 2017–2027

Figure 37: Global CRO Services Market Value (US$ Mn) Forecast, by Phase II, 2017–2027

Figure 38: Global CRO Services Market Value (US$ Mn) Forecast, by Phase III, 2017–2027

Figure 39: Global CRO Services Market Value (US$ Mn) Forecast, by Phase IV, 2017–2027

Figure 40: Global CRO Services Market Value (US$ Mn) Forecast, by Bio-analytical services, 2017–2027

Figure 41: Global CRO Services Market Value (US$ Mn) Forecast, by Analytical Services, 2017–2027

Figure 42: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

Figure 43: Global CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 44: Global CRO Services Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

Figure 45: Global CRO Services Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017–2027

Figure 46: Global CRO Services Market Value (US$ Mn) Forecast, by Immunological Disorders, 2017–2027

Figure 47: Global CRO Services Market Value (US$ Mn) Forecast, by Respiratory Diseases, 2017–2027

Figure 48: Global CRO Services Market Value (US$ Mn) Forecast, by Cardiovascular Diseases, 2017–2027

Figure 49: Global CRO Services Market Value (US$ Mn) Forecast, by Neurological Disorders, 2017–2027

Figure 50: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

Figure 51: Global CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 52: Global CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 53: Global CRO Services Market Value (US$ Mn) Forecast, by Medical Device Companies , 2017–2027

Figure 54: Global CRO Services Market Value (US$ Mn) Forecast, by Biopharmaceutical Companies, 2017–2027

Figure 55: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

Figure 56: Global CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 57: Global CRO Services Market: Regional Outlook

Figure 58: Global CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 59: Global CRO Services Market Value Share Analysis, by Region, 2018 and 2027

Figure 60: Global CRO Services Market Attractiveness, by Region, 2019?2027

Figure 61: North America CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 62: North America CRO Services Market Attractiveness Analysis, by Country, 2019–2027

Figure 63: North America CRO Services Market Value Share Analysis, by Country, 2018 and 2027

Figure 64: North America CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 65: North America CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 66: North America CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 67: North America CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 68: North America CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 69: North America CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 70: North America CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 71: North America CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 72: North America CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 73: North America CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 74: North America CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 75: North America CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 76: Europe CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 77: Europe CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 78: Europe CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 79: Europe CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 80: Europe CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 81: Europe CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 82: Europe CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 83: Europe CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 84: Europe CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 85: Europe CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 86: Europe CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 87: Europe CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 88: Europe CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 89: Europe CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 90: Europe CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 91: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 92: Asia Pacific CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 93: Asia Pacific CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 94: Asia Pacific CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 95: Asia Pacific CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 96: Asia Pacific CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 97: Asia Pacific CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 98: Asia Pacific CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 99: Asia Pacific CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 100: Asia Pacific CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 101: Asia Pacific CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 102: Asia Pacific CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 103: Asia Pacific CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 104: Asia Pacific CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 105: Asia Pacific CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 106: Latin America CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 107: Latin America CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 108: Latin America CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 109: Latin America CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 110: Latin America CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 111: Latin America CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 112: Latin America CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 113: Latin America CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 114: Latin America CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 115: Latin America CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 116: Latin America CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 117: Latin America CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 118: Latin America CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 119: Latin America CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 120: Latin America CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 121: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, 2017–2027

Figure 122: Middle East & Africa CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 123: Middle East & Africa CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 124: Middle East & Africa CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

Figure 125: Middle East & Africa CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

Figure 126: Middle East & Africa CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

Figure 127: Middle East & Africa CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

Figure 128: Middle East & Africa CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

Figure 129: Middle East & Africa CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

Figure 130: Middle East & Africa CRO Services Market Attractiveness, by Service Type, 2019?2027

Figure 131: Middle East & Africa CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

Figure 132: Middle East & Africa CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

Figure 133: Middle East & Africa CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

Figure 134: Middle East & Africa CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

Figure 135: Middle East & Africa CRO Services Market Attractiveness, by End-user, 2019?2027

Figure 136: Global CRO Services Market Share, by Company, 2018

Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports

+